US Congress House Bill 4209 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Democrat 32-12)
Status: Introduced on March 19 2012 - 25% progression, died in committee
Action: 2012-03-19 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Patients' Access to Treatments Act of 2012 - Amends the Public Health Service Act to prohibit a health plan offering group or individual health insurance that provides coverage for prescription drugs and uses a formulary or other tiered cost-sharing structure from imposing co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of such requirements applicable to prescription drugs in a non-preferred brand drug tier. Provides that if a formulary used by such a health plan contains more than one non-preferred brand drug tier, such prohibition shall be applied with respect to the non-preferred brand drug tier for which beneficiary cost-sharing is lowest. Defines: (1) "non-preferred brand drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs in the plan's formulary, that are prescription drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary and that are prescription drugs.

Patients' Access to Treatments Act of 2012

Rep. David McKinley [R-WV]	Rep. Spencer Bachus [R-AL]	Rep. Roscoe Bartlett [R-MD]	Rep. Timothy Bishop [D-NY]
Rep. Suzanne Bonamici [D-OR]	Rep. Jo Bonner [R-AL]	Rep. Leonard Boswell [D-IA]	Sen. Shelley Capito [R-WV]
Rep. Lois Capps [D-CA]	Rep. David Cicilline [D-RI]	Rep. John Conyers [D-MI]	Rep. Joe Courtney [D-CT]
Rep. Ander Crenshaw [R-FL]	Rep. Henry Cuellar [D-TX]	Rep. Danny Davis [D-IL]	Rep. Susan Davis [D-CA]
Rep. Peter DeFazio [D-OR]	Rep. Theodore Deutch [D-FL]	Rep. Sam Farr [D-CA]	Rep. Barney Frank [D-MA]
Rep. Jim Gerlach [R-PA]	Rep. Gregg Harper [R-MS]	Rep. Rush Holt [D-NJ]	Rep. Jesse Jackson [D-IL]
Rep. Henry Johnson [D-GA]	Rep. James Langevin [D-RI]	Sen. Edward Markey [D-MA]	Rep. Jim McDermott [D-WA]
Rep. James McGovern [D-MA]	Rep. Michael Michaud [D-ME]	Rep. James Moran [D-VA]	Rep. Ed Pastor [D-AZ]
Rep. Chellie Pingree [D-ME]	Rep. Charles Rangel [D-NY]	Rep. Steven Rothman [D-NJ]	Rep. Lucille Roybal-Allard [D-CA]
Rep. Jon Runyan [R-NJ]	Rep. Paul Tonko [D-NY]	Rep. Edolphus Towns [D-NY]	Sen. Peter Welch [D-VT]
Rep. Frank Wolf [R-VA]	Rep. Lynn Woolsey [D-CA]	Rep. C.W. Young [R-FL]	Rep. Don Young [R-AK]

Date	Chamber	Action
2012-03-19	House	Referred to the House Committee on Energy and Commerce.

Type	Source
Summary	https://www.congress.gov/bill/112th-congress/house-bill/4209/all-info
Text	https://www.congress.gov/112/bills/hr4209/BILLS-112hr4209ih.pdf